 Connection
Max Wohlauer to Time-to-Treatment
This is a "connection" page, showing publications Max Wohlauer has written about Time-to-Treatment.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.344 |
|
|
|
-
Moore E, Wohlauer MV, Dorosh J, Kabeil M, Malgor RD, O'Banion LA, Lopez-Pena G, Gillette R, Colborn K, Cuff RF, Lucero L, Ali A, Koleilat I, Batarseh P, Talathi S, Rivera A, Humphries MD, Ly K, Harroun N, Smith BK, Darelli-Anderson AM, Choudhry A, Hammond E, Costanza M, Khetarpaul V, Cosentino A, Watson J, Afifi R, Mouawad NJ, Tan TW, Sharafuddin M, Quevedo JP, Nkansah R, Shibale P, Shalhub S, Lin JC. Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease. Vascular. 2025 Apr; 33(2):367-375.
Score: 0.195
-
Mouawad NJ, Cuff RF, Hultgren R, Chuen J, Galeazzi E, Wohlauer M. The Vascular Surgery COVID-19 Collaborative (VASCC). J Vasc Surg. 2020 07; 72(1):379-380.
Score: 0.149
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|